Digital Therapeutics Market Opportunity, growth drivers and key developments during 2017-2025

Press Release

KD market research provides a forecast for global Digital Therapeutics Market for a span of 6 years i.e. between 2017 and 2025.  In terms of value, market is going to register a 20.5% CAGR during the forecast years. The provided research provides the market trends and dynamics across seven regions: North America, Latin America, Europe, APAC and Middle East & Africa. These regions influence both current and future status for Digital Therapeutics Market over the forecast period.

The global digital therapeutics market was valued at $1,751 million in 2017 and is expected to reach $7,833 million by 2025, registering a CAGR of 20.5% during the forecast period. Digital therapeutics is a type of treatment option, which utilizes online health technologies and digital devices to treat numerous medical conditions and help maintain health discipline.

Request for Sample @ https://www.kdmarketresearch.com/sample/3528

Increase in adoption of smartphones & tablets coupled with rise in utilization of healthcare apps is the major factor that drives the growth of the global digital therapeutics market. In addition, increasing need to control healthcare costs supplements the market growth. However, lack of awareness regarding the availability of smartphone applications, especially in the developing countries, acts a major deterrent to the market growth. Conversely, high growth potential in the developing markets is expected to offer significant opportunities for the players operating in this market.

The global digital therapeutics market is segmented into application, product, sales channel, and region. Based on application, the market is divided into diabetes, obesity, cardiovascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. On the basis of product, it is classified into software and devices. By sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumers (B2C). Furthermore, the business – to – business (B2B) segment is categorized into employers, healthcare providers, and others. Depending on business-to-consumers, the market is fragmented into patients and caregivers. Regionally, it is analyzed across North America, Europe, Asia – Pacific, and LAMEA.

Key benefits for Digital Therapeutics Market:

The study provides an in-depth analysis of the global digital therapeutics market along with current trends and future estimations to elucidate the imminent investment pockets.

Comprehensive analysis of the factors that drive and restrict the market growth is provided.

Comprehensive quantitative analysis of the industry from 2017 to 2025 is provided to enable stakeholders to capitalize on the prevailing market opportunities.

Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally.

Key market players and their strategies are provided to understand the competitive outlook of the market.

Digital Therapeutics Key market segments:

By Application

Diabetes

Obesity

Cardiovascular Disease (CVD)

Central Nervous System (CNS) Disease

Respiratory Disease

Smoking Cessation

Gastrointestinal Disorder (GID)

Others

By Product

Software

Device

By Sales Channel

Business-to-business (B2B)

Employer

Healthcare Provider

Others

Business-to-consumer (B2C)

Patient

Caregiver

By Region

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Rest of Europe

Asia-Pacific

Japan

China

Australia

India

South Korea

Rest of Asia-Pacific

LAMEA

Brazil

Turkey

Saudi Arabia

South Africa

Rest of LAMEA

Browse Full Report With [email protected] https://www.kdmarketresearch.com/report/digital-therapeutics-market-amrr

Table of Content

CHAPTER 1: INTRODUCTION

1.1.Report description

1.2.Key benefits for stakeholders

1.3.key market segments

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top investment pockets

3.2.2. Top Winning Strategies

3.2.3. Top Player Positioning, 2017

3.3. Porters five forces analysis

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in adoption of smartphone and tablets coupled with healthcare apps

3.4.1.2. Growth in need to control healthcare costs

3.4.1.3. Rise in incidence of chronic diseases

3.4.2. Restraints

3.4.2.1. Lack of awareness regarding digital therapeutics in developing countries

3.4.2.2. Patient data privacy concerns

3.4.3. Opportunity

3.4.3.1. Emerging markets offer significant growth opportunities

CHAPTER 4: DIGITAL THERAPEUTICS MARKET, BY APPLICATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Diabetes

4.2.1. Key market trends and growth opportunities

4.2.2. Market size and forecast

4.2.3. Market analysis, by country

4.3. Obesity

4.3.1. Key market trends and growth opportunities

4.3.2. Market size and forecast

4.3.3. Market analysis, by country

4.4. Cardiovascular diseases

4.4.1. Key market trends and growth opportunities

4.4.2. Market size and forecast

4.4.3. Market analysis, by country

4.5. Central nervous system (cns) diseases

4.5.1. Key market trends and growth opportunities

4.5.2. Market size and forecast

4.5.3. Market analysis, by country

4.6. Gastrointestinal disorder

4.6.1. Key market trends and growth opportunities

4.6.2. Market size and forecast

4.6.3. Market analysis, by country

4.7. Respiratory diseases

4.7.1. Key market trends and growth opportunities

4.7.2. Market size and forecast

4.7.3. Market analysis, by country

4.8. Smoking cessation

4.8.1. Key market trends and growth opportunities

4.8.2. Market size and forecast

4.8.3. Market analysis, by country

4.9. Others

4.9.1. Key market trends and growth opportunities

4.9.2. Market size and forecast

4.9.3. Market analysis, by country

CHAPTER 5: DIGITAL THERAPEUTICS MARKET, BY PRODUCT

5.1. Overview

5.1.1. Market size and forecast

5.2. Software

5.2.1. Market size and forecast

5.2.2. Market analysis, by country

5.3. Devices

5.3.1. Market size and forecast

5.3.2. Market analysis, by country

CHAPTER 6: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL

6.1. Overview

6.1.1. Market size and forecast

6.2. Business-To-Business (b2b)

6.2.1. Market size and forecast, by type

6.2.2. Market size and forecast, by region

6.2.3. Market analysis, by country

6.2.4. Employer

6.2.4.1. Market size and forecast

6.2.5. Healthcare Providers

6.2.5.1. Market size and forecast

6.2.6. Others

6.2.6.1. Market size and forecast

6.3. Business-to-consumers

6.3.1. Market size and forecast, by type

6.3.2. Market size and forecast, by region

6.3.3. Market analysis, by country

6.3.4. Patients

6.3.4.1. Market size and forecast

6.3.5. Caregivers

6.3.5.1. Market size and forecast

CHAPTER 7: DIGITAL THERAPEUTICS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North america

7.2.1. Key market trends, growth factors, and opportunities

7.2.2. North America digital therapeutics market, by country

7.2.2.1. U.S. digital therapeutics market by application

7.2.2.2. U.S digital therapeutics market by product type

7.2.2.3. U.S. digital therapeutics market by sales channel

7.2.2.4. Canada digital therapeutics market by application

7.2.2.5. Canada digital therapeutics market by product type

7.2.2.6. Canada digital therapeutics market by sales channel

7.2.2.7. Mexico digital therapeutics market by application

7.2.2.8. Mexico digital therapeutics market by product type

7.2.2.9. Mexico digital therapeutics market by sales channel

7.2.3. North America digital therapeutics market, by application

7.2.4. North America digital therapeutics market, by product type

7.2.5. North America digital therapeutics market, by sales channel

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities

7.3.2. Europe digital therapeutics market, by country

7.3.2.1. UK digital therapeutics market by application

7.3.2.2. UK digital therapeutics market by product type

7.3.2.3. UK digital therapeutics market by sales channel

7.3.2.4. Germany digital therapeutics market by application

7.3.2.5. Germany digital therapeutics market by product type

7.3.2.6. Germany digital therapeutics market by sales channel

7.3.2.7. France digital therapeutics market by application

7.3.2.8. France digital therapeutics market by product type

7.3.2.9. France digital therapeutics market by sales channel

7.3.2.10. Italy digital therapeutics market by application

7.3.2.11. Italy digital therapeutics market by product type

7.3.2.12. Italy digital therapeutics market by sales channel

7.3.2.13. Spain digital therapeutics market by application

7.3.2.14. Spain digital therapeutics market by product type

7.3.2.15. Spain digital therapeutics market by sales channel

7.3.2.16. Rest of Europe digital therapeutics market by application

7.3.2.17. Rest of Europe digital therapeutics market by product type

7.3.2.18. Rest of Europe digital therapeutics market by sales channel

7.3.3. Europe digital therapeutics market, by application

7.3.4. Europe digital therapeutics market, by product type

7.3.5. Europe digital therapeutics market, by sales channel

7.4. Asia-pacific

7.4.1. Key market trends, growth factors, and opportunities

7.4.2. Asia-Pacific digital therapeutics market, by country

7.4.2.1. Japan digital therapeutics market by application

7.4.2.2. Japan digital therapeutics market by product type

7.4.2.3. Japan digital therapeutics market by sales channel

7.4.2.4. China digital therapeutics market by application

7.4.2.5. China digital therapeutics market by product type

7.4.2.6. China digital therapeutics market by sales channel

7.4.2.7. Australia digital therapeutics market by application

7.4.2.8. Australia digital therapeutics market by product type

7.4.2.9. Australia digital therapeutics market by sales channel

7.4.2.10. India digital therapeutics market by application

7.4.2.11. India digital therapeutics market by product type

7.4.2.12. India digital therapeutics market by sales channel

7.4.2.13. South Korea digital therapeutics market by application

7.4.2.14. South Korea digital therapeutics market by product type

7.4.2.15. South Korea digital therapeutics market by sales channel

7.4.2.16. Rest of Asia-Pacific digital therapeutics market by application

7.4.2.17. Rest of Asia-Pacific digital therapeutics market by product type

7.4.2.18. Rest of Asia-Pacific digital therapeutics market by sales channel

7.4.3. Asia-Pacific digital therapeutics market, by application

7.4.4. Asia-Pacific digital therapeutics market, by product type

7.4.5. Asia-Pacific digital therapeutics market, by sales channel

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities

7.5.2. LAMEA digital therapeutics market, by country

7.5.2.1. Brazil digital therapeutics market by application

7.5.2.2. Brazil digital therapeutics market by product type

7.5.2.3. Brazil digital therapeutics market by sales channel

7.5.2.4. Turkey digital therapeutics market by application

7.5.2.5. Turkey digital therapeutics market by product type

7.5.2.6. Turkey digital therapeutics market by sales channel

7.5.2.7. Saudi Arabia digital therapeutics market by application

7.5.2.8. Saudi Arabia digital therapeutics market by product type

7.5.2.9. Saudi Arabia digital therapeutics market by sales channel

7.5.2.10. South Africa digital therapeutics market by application

7.5.2.11. South Africa digital therapeutics market by product type

7.5.2.12. South Africa digital therapeutics market by sales channel

7.5.2.13. Rest of LAMEA digital therapeutics market by application

7.5.2.14. Rest of LAMEA digital therapeutics market by product type

7.5.2.15. Rest of LAMEA digital therapeutics market by sales channel

7.5.3. LAMEA digital therapeutics market, by application

7.5.4. LAMEA digital therapeutics market, by product type

7.5.5. LAMEA digital therapeutics market, by sales channel

Continue….

Check for Discount @ https://www.kdmarketresearch.com/discount/3528

About Us:

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us:

KD Market Research

150 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email: [email protected]

Website: https://www.kdmarketresearch.com

More [email protected] https://marketresearchtab.com/

More [email protected] https://marketnewsbizz.com/

https://kdmarketinsightsblog.com/